Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
Cogliano
Vincent
V
Grosse
Yann
Y
Baan
Robert
R
Straif
Kurt
K
Secretan
Béatrice
B
El Ghissassi
Fatiha
F
D000818:Animals; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008593:Menopause; D009369:Neoplasms / Q000139:chemically induced* / Q000517:prevention & control; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D011372:Progestins